Skip to Content

Diagnosing Disease with Paper and Tape

By adding tape, researchers can make more-complex tests that are portable and cheap.

On the desk of Harvard University professor George Whitesides are white sheets the size of stamps. Each is inlaid with a different pattern: a four-leaf flower, concentric circles surrounding four dots, a six-pointed burst. These prototypes are diagnostic tests made from a cheap, universally available substrate: paper. With the simple addition of tape, Whitesides and his group have been able to turn their paper tests into three-dimensional devices, allowing for more-complicated analysis. Such paper “lab on a chip” tests may lead to a cost-effective, portable, and accurate method for diagnosing diseases in countries lacking reliable health care.

Flowing liquid: In this three-dimensional device, dyes move through four channels in a basket-weave pattern. By using several alternating layers of treated paper and perforated waterproof tape, the researchers are able to direct liquids to different testing areas.

Whitesides holds up his group’s latest development: a square slightly thicker than the other samples, covered in a grid of yellow, greed, red, and blue dots. This prototype is made up of layers of patterned paper, between which are waterproof double-sided tape. By layering the squares and connecting them with tape adhesive, the group is able to channel liquid horizontally and vertically in a very small area, as detailed in this week’s Proceedings of the National Academy of Sciences.

Each square of paper–which naturally soaks up liquid in its fibers–has been treated with photoresist material, to create channels that funnel liquid to tiny wells coated with proteins or antibodies. The fluid interacts with that area of the paper and turns the well a certain color, changing hues, for example, with varying concentrations of glucose.

“You can effectively make three-dimensional systems,” says Whitesides. “You can distribute fluid from a single point of origin to multiple points elsewhere.” Most microfluidic systems, he adds, require sophisticated piping to channel the fluid, but just by drawing water-resistant channels in the paper and using waterproof tape, the researchers have been able to control the movement of the liquid.

A sample of biological fluid is pressed onto one side of the paper chip. Photoresist channels guide the fluid to certain wells and ultimately through a tiny hole in the waterproof tape, which funnels the liquid on to the next piece of paper. This process continues for each layer of the chip, and the results appear in a dotted grid on the final layer.

Dip and test: This three-dimensional device can test four samples for four different analytes. The researchers dipped each corner of the device into artificial urine samples to detect glucose and protein. Samples move through the device into the different test zones. White to brown shows the presence of glucose, while yellow to blue indicates protein. (The first sample had neither glucose nor protein.)

According to Whitesides, “Each dot would be a different test” that could be performed using a single drop of blood serum. Currently, the researchers layer the paper and tape by hand, which Whitesides says is fairly easy to do, but they hope that eventually a device could be made to print the tape and paper.

The group has focused on readily accessible materials, so the device can be robust and used in a variety of environments and in developing countries. They chose paper because its natural capillary action circumvents the need for expensive or cumbersome pumps and power sources to move the liquid (as would be needed for polymer or glass microfluidic devices). In that way, the device is similar to how pH paper or a pregnancy test works. But Whitesides aims for his tests to diagnose much more, as well as be portable, cheap to manufacture, and easy for those in developing countries or in military or emergency respond teams to use and adapt.

“These paper-based devices may allow significantly cheaper and portable analytical devices for diagnostics in the developing countries,” says Mehmet Fatih Yanik, an assistant professor of electrical engineering at MIT, who works on lab-on-a-chip imaging. “They could also allow routine conduction of hundreds of assays cheaply, which may allow early and precise diagnostics of severe diseases, significantly reducing the health-care burden,” he adds.

Although the tests are still in the research and development phase, Whitesides says, so far, they seem to be highly accurate. Whitesides has already cofounded a nonprofit, Diagnostics for All, to further develop and distribute the tests in a developing country. (Diagnostics for All won the MIT $100K Entrepreneurship Competition earlier this year.)

The researchers have also begun work on coupling the paper tests with cell phones, so that the results can be photographed, sent to a center, and read by a technician who can send recommendations back via phone.

Keep Reading

Most Popular

DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.

“This is a profound moment in the history of technology,” says Mustafa Suleyman.

What to know about this autumn’s covid vaccines

New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.

Human-plus-AI solutions mitigate security threats

With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure

Next slide, please: A brief history of the corporate presentation

From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.